[go: up one dir, main page]

TR200909613A1 - Pregabalinin farmasötik bileşimleri. - Google Patents

Pregabalinin farmasötik bileşimleri.

Info

Publication number
TR200909613A1
TR200909613A1 TR2009/09613A TR200909613A TR200909613A1 TR 200909613 A1 TR200909613 A1 TR 200909613A1 TR 2009/09613 A TR2009/09613 A TR 2009/09613A TR 200909613 A TR200909613 A TR 200909613A TR 200909613 A1 TR200909613 A1 TR 200909613A1
Authority
TR
Turkey
Prior art keywords
pregabalin
pharmaceutical compositions
pharmaceutically acceptable
acceptable salt
heat
Prior art date
Application number
TR2009/09613A
Other languages
English (en)
Inventor
Toksöz Ahmet
Türkyilmaz Ali̇
Öner Levent
Yildirim Ayli̇n
Demi̇r Vi̇ldan
Pehli̇van Akalin Nur
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2009/09613A priority Critical patent/TR200909613A1/tr
Priority to EP10196217.3A priority patent/EP2343055B1/en
Publication of TR200909613A1 publication Critical patent/TR200909613A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş, pregabalin veya pregabalinin farmasötik olarak kabul edilebilir bir tuzu ile kolloidal silikon dioksit içermektedir Daha özel olarak bu buluş, pregabalininin ısı ve nem etkisine dayanıklı ve stabil kapsül formu ile ilgilidir.
TR2009/09613A 2009-12-22 2009-12-22 Pregabalinin farmasötik bileşimleri. TR200909613A1 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/09613A TR200909613A1 (tr) 2009-12-22 2009-12-22 Pregabalinin farmasötik bileşimleri.
EP10196217.3A EP2343055B1 (en) 2009-12-22 2010-12-21 Pharmaceutical compositions of pregabalin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/09613A TR200909613A1 (tr) 2009-12-22 2009-12-22 Pregabalinin farmasötik bileşimleri.

Publications (1)

Publication Number Publication Date
TR200909613A1 true TR200909613A1 (tr) 2011-07-21

Family

ID=42335009

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/09613A TR200909613A1 (tr) 2009-12-22 2009-12-22 Pregabalinin farmasötik bileşimleri.

Country Status (2)

Country Link
EP (1) EP2343055B1 (tr)
TR (1) TR200909613A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2826470B1 (en) 2013-07-19 2017-09-06 Arven Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of pregabalin
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
CN112245404A (zh) * 2020-11-02 2021-01-22 成都晶富医药科技有限公司 一种普瑞巴林胶囊及其制备方法
EP4230199A4 (en) 2020-12-04 2024-07-31 Laboratorios Silanes, S.A. de C.V. COATED AND STABLE SOLID PHARMACEUTICAL COMPOSITION OF AN ANALGESIC AND AN ANTIEPILEPTIC AGAINST PAIN

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012679A1 (en) * 1998-08-03 2002-01-31 Societe Laboratoires Des Produits Ethiques - Ethypharm Process for manufacturing coated gabapentin or pregabalin particles
US20020098227A1 (en) * 1999-07-08 2002-07-25 Ethypharm Process for manufacturing coated granules with masked taste and immediate release of the active principle
WO2008128775A2 (en) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilised pharmaceutical composition containing pregabaline
WO2009066325A1 (en) * 2007-11-23 2009-05-28 Lupin Limited Controlled release pharmaceutical compositions of pregabalin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014228A1 (en) 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
WO2008140460A1 (en) 2007-05-16 2008-11-20 Fmc Corporation Solid form
WO2008140459A1 (en) 2007-05-16 2008-11-20 Fmc Corporation Solid form

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012679A1 (en) * 1998-08-03 2002-01-31 Societe Laboratoires Des Produits Ethiques - Ethypharm Process for manufacturing coated gabapentin or pregabalin particles
US20020098227A1 (en) * 1999-07-08 2002-07-25 Ethypharm Process for manufacturing coated granules with masked taste and immediate release of the active principle
WO2008128775A2 (en) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilised pharmaceutical composition containing pregabaline
WO2009066325A1 (en) * 2007-11-23 2009-05-28 Lupin Limited Controlled release pharmaceutical compositions of pregabalin

Also Published As

Publication number Publication date
EP2343055B1 (en) 2017-10-18
EP2343055A1 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
JOP20200039A1 (ar) مُستحضر صيدلي يشتمل على hcg مأشوب
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
EA201390081A1 (ru) Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение
EA201170441A1 (ru) Терапевтические противовирусные пептиды
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
UA108636C2 (xx) Пептид
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
EA201171366A1 (ru) Противоопухолевая комбинация, содержащая ave8062 и сорафениб
EA201290792A1 (ru) Пептиды для вакцины против аллергии на березу
TR200908237A2 (tr) Kalsiyum ve D vitamini içeren farmasötik bileşimler.
TR200909613A1 (tr) Pregabalinin farmasötik bileşimleri.
TN2012000105A1 (en) Spirolactam derivatives and uses of same
EA201001353A1 (ru) Гидробромид ивабрадина
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
UA110921C2 (uk) Пептид
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
TR201000948A1 (tr) Aripiprazol formülasyonları.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR201007508A1 (tr) Oral yolla dağılan bileşimler
MX2012007097A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
TR201010859A2 (tr) Sefdinir içeren tablet formları.